Foundry Investment Discipline Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1APP | APPLOVIN CORP | Technology | $142.62B | 14.17% |
2SRE | SEMPRA | Utilities | $60.30B | 5.99% |
3ONC | BEONE MEDICINES LTD | Healthcare | $34.68B | 3.45% |
4CCI | CROWN CASTLE INC | Real Estate | $34.55B | 3.43% |
5ON | ON SEMICONDUCTOR CORP | Technology | $34.24B | 3.40% |
6STLD | STEEL DYNAMICS INC | Basic Materials | $33.96B | 3.37% |
7ZM | ZOOM COMMUNICATIONS INC | Technology | $26.72B | 2.65% |
8EQR | EQUITY RESIDENTIAL | Real Estate | $25.85B | 2.57% |
9MDB | MONGODB INC | Technology | $25.12B | 2.50% |
10MRNA | MODERNA INC | Healthcare | $24.53B | 2.44% |
11SBAC | SBA COMMUNICATIONS CORP | Real Estate | $19.69B | 1.96% |
12DD | DUPONT DE NEMOURS INC | Basic Materials | $18.49B | 1.84% |
13BEN | FRANKLIN RESOURCES INC | Financial Services | $16.96B | 1.68% |
14TLN | TALEN ENERGY CORP | Utilities | $16.90B | 1.68% |
15GEN | GEN DIGITAL INC | Technology | $16.11B | 1.60% |
16ALB | ALBEMARLE CORP | Basic Materials | $14.24B | 1.42% |
17EXEL | EXELIXIS INC | Healthcare | $14.06B | 1.40% |
18EQH | EQUITABLE HOLDINGS INC | Financial Services | $13.79B | 1.37% |
19AMH | AMERICAN HOMES 4 RENT | Real Estate | $12.29B | 1.22% |
20CPT | CAMDEN PROPERTY TRUST | Real Estate | $11.36B | 1.13% |
21CGNX | COGNEX CORP | Technology | $10.66B | 1.06% |
22ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 1.04% |
23APGE | APOGEE THERAPEUTICS INC | Healthcare | $10.10B | 1.00% |
24SSB | SOUTHSTATE BANK CORP | Financial Services | $10.08B | 1.00% |
25CORT | CORCEPT THERAPEUTICS INC | Healthcare | $9.72B | 0.97% |
26KYMR | KYMERA THERAPEUTICS INC | Healthcare | $9.52B | 0.95% |
27REXR | REXFORD INDUSTRIAL REALTY INC | Real Estate | $8.46B | 0.84% |
28IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 0.82% |
29PCVX | VAXCYTE INC | Healthcare | $8.12B | 0.81% |
30DBX | DROPBOX INC | Technology | $7.14B | 0.71% |
31LNTH | LANTHEUS HOLDINGS INC | Healthcare | $7.00B | 0.70% |
32XENE | XENON PHARMACEUTICALS INC | Healthcare | $6.60B | 0.66% |
33RYN | RAYONIER INC | Real Estate | $6.56B | 0.65% |
34PTCT | PTC THERAPEUTICS INC | Healthcare | $6.52B | 0.65% |
35GATX | GATX CORP | Industrials | $6.34B | 0.63% |
36PATH | UIPATH INC | Technology | $6.30B | 0.63% |
37RIG | TRANSOCEAN LTD | Energy | $5.74B | 0.57% |
38QLYS | QUALYS INC | Technology | $5.61B | 0.56% |
39LAZ | LAZARD INC | Financial Services | $4.82B | 0.48% |
40SKT | TANGER INC | Real Estate | $4.80B | 0.48% |
41FULT | FULTON FINANCIAL CORP | Financial Services | $4.74B | 0.47% |
42KRC | KILROY REALTY CORP | Real Estate | $4.68B | 0.46% |
43TCBI | TEXAS CAPITAL BANCSHARES INC | Financial Services | $4.59B | 0.46% |
44LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.44% |
45INSW | INTERNATIONAL SEAWAYS INC | Energy | $4.29B | 0.43% |
46GPGI | GPGI INC | Industrials | $4.21B | 0.42% |
47OPLN | OPENLANE INC | Consumer Cyclical | $4.18B | 0.42% |
48WSFS | WSFS FINANCIAL CORP | Financial Services | $4.16B | 0.41% |
49LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.40% |
50THO | THOR INDUSTRIES INC | Consumer Cyclical | $3.97B | 0.39% |
51WSBC | WESBANCO INC | Financial Services | $3.92B | 0.39% |
52NHI | NATIONAL HEALTH INVESTORS INC | Real Estate | $3.86B | 0.38% |
53CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.38% |
54RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.38% |
55DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.37% |
56NIC | NICOLET BANKSHARES INC | Financial Services | $3.61B | 0.36% |
57ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.56B | 0.35% |
58BKU | BANKUNITED INC | Financial Services | $3.55B | 0.35% |
59CRGY | CRESCENT ENERGY CO | Energy | $3.55B | 0.35% |
60CALY | CALLAWAY GOLF CO | Consumer Cyclical | $3.48B | 0.35% |
61RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.34% |
62CLSK | CLEANSPARK INC | Financial Services | $3.34B | 0.33% |
63PPLI | PEOPLE INC | Communication Services | $3.31B | 0.33% |
64SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.32% |
65SAH | SONIC AUTOMOTIVE INC | Consumer Cyclical | $3.17B | 0.32% |
66CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.31% |
67MMS | MAXIMUS INC | Industrials | $3.06B | 0.30% |
68AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.30% |
69AKR | ACADIA REALTY TRUST | Real Estate | $3.00B | 0.30% |
70BELFA | BEL FUSE INC | Technology | $2.91B | 0.29% |
71IRON | DISC MEDICINE INC | Healthcare | $2.91B | 0.29% |
72APAM | ARTISAN PARTNERS ASSET MANAGEMENT INC | Financial Services | $2.73B | 0.27% |
73DJT | TRUMP MEDIA & TECHNOLOGY GROUP CORP | Communication Services | $2.68B | 0.27% |
74KALU | KAISER ALUMINUM CORP | Basic Materials | $2.58B | 0.26% |
75QURE | UNIQURE NV | Healthcare | $2.54B | 0.25% |
76VCEL | VERICEL CORP | Healthcare | $2.38B | 0.24% |
77BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.23% |
78NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.31B | 0.23% |
79HTH | HILLTOP HOLDINGS INC | Financial Services | $2.26B | 0.22% |
80PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.26B | 0.22% |
81MLYS | MINERALYS THERAPEUTICS INC | Healthcare | $2.23B | 0.22% |
82AGM | FEDERAL AGRICULTURAL MORTGAGE CORP | Financial Services | $2.23B | 0.22% |
83SHO | SUNSTONE HOTEL INVESTORS INC | Real Estate | $2.19B | 0.22% |
84PEB | PEBBLEBROOK HOTEL TRUST | Real Estate | $2.16B | 0.21% |
85SGRY | SURGERY PARTNERS INC | Healthcare | $2.09B | 0.21% |
86RAPP | RAPPORT THERAPEUTICS INC | Healthcare | $2.04B | 0.20% |
87HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 0.19% |
88TYRA | TYRA BIOSCIENCES INC | Healthcare | $1.91B | 0.19% |
89CCS | CENTURY COMMUNITIES INC | Consumer Cyclical | $1.89B | 0.19% |
90IIPR | INNOVATIVE INDUSTRIAL PROPERTIES INC | Real Estate | $1.86B | 0.18% |
91SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.82B | 0.18% |
92SONO | SONOS INC | Technology | $1.80B | 0.18% |
93GEL | GENESIS ENERGY LP | Energy | $1.79B | 0.18% |
94NN | NEXTNAV INC | Technology | $1.78B | 0.18% |
95DCOM | DIME COMMUNITY BANCSHARES INC | Financial Services | $1.78B | 0.18% |
96AESI | ATLAS ENERGY SOLUTIONS INC | Energy | $1.76B | 0.17% |
97ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.17% |
98GLP | GLOBAL PARTNERS LP | Energy | $1.63B | 0.16% |
99KRP | KIMBELL ROYALTY PARTNERS LP | Energy | $1.61B | 0.16% |
100INVA | INNOVIVA INC | Healthcare | $1.60B | 0.16% |
101NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.16% |
102GBX | GREENBRIER COMPANIES INC | Industrials | $1.55B | 0.15% |
103CSWC | CAPITAL SOUTHWEST CORP | Financial Services | $1.51B | 0.15% |
104WWW | WOLVERINE WORLD WIDE INC | Consumer Cyclical | $1.51B | 0.15% |
105MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.14% |
106MRTN | MARTEN TRANSPORT LTD | Industrials | $1.44B | 0.14% |
107ULCC | FRONTIER GROUP HOLDINGS INC | Industrials | $1.43B | 0.14% |
108TWFG | TWFG INC | Financial Services | $1.43B | 0.14% |
109VPG | VISHAY PRECISION GROUP INC | Technology | $1.38B | 0.14% |
110STAA | STAAR SURGICAL CO | Healthcare | $1.32B | 0.13% |
111DMLP | DORCHESTER MINERALS LP | Energy | $1.31B | 0.13% |
112UFCS | UNITED FIRE GROUP INC | Financial Services | $1.31B | 0.13% |
113XNCR | XENCOR INC | Healthcare | $1.30B | 0.13% |
114ABSI | ABSCI CORP | Healthcare | $1.29B | 0.13% |
115INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.13% |
116LADR | LADDER CAPITAL CORP | Real Estate | $1.28B | 0.13% |
117IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.12% |
118SAFE | SAFEHOLD INC | Real Estate | $1.22B | 0.12% |
119OSBC | OLD SECOND BANCORP INC | Financial Services | $1.22B | 0.12% |
120HTLD | HEARTLAND EXPRESS INC | Industrials | $1.19B | 0.12% |
121ORIC | ORIC PHARMACEUTICALS INC | Healthcare | $1.11B | 0.11% |
122CRAI | CRA INTERNATIONAL INC | Industrials | $1.11B | 0.11% |
123CIM | CHIMERA INVESTMENT CORP | Real Estate | $1.08B | 0.11% |
124MCBS | METROCITY BANKSHARES INC | Financial Services | $1.04B | 0.10% |
125UTZ | UTZ BRANDS INC | Consumer Defensive | $1.04B | 0.10% |
126CPF | CENTRAL PACIFIC FINANCIAL CORP | Financial Services | $1.02B | 0.10% |
127CCNE | CNB FINANCIAL CORP | Financial Services | $1.02B | 0.10% |
128OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | $1.00B | 0.10% |
129VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.10% |
130ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.10% |
131LWLG | LIGHTWAVE LOGIC INC | Basic Materials | $960M | 0.10% |
132APEI | AMERICAN PUBLIC EDUCATION INC | Consumer Defensive | $930M | 0.09% |
133CAC | CAMDEN NATIONAL CORP | Financial Services | $917M | 0.09% |
134TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.09% |
135NPK | NATIONAL PRESTO INDUSTRIES INC | Industrials | $870M | 0.09% |
136LMB | LIMBACH HOLDINGS INC | Industrials | $867M | 0.09% |
137FMNB | FARMERS NATIONAL BANC CORP | Financial Services | $867M | 0.09% |
138HPP | HUDSON PACIFIC PROPERTIES INC | Real Estate | $853M | 0.08% |
139HTB | HOMETRUST BANCSHARES INC | Financial Services | $824M | 0.08% |
140ADAM | ADAMAS TRUST INC | Real Estate | $807M | 0.08% |
141FPH | FIVE POINT HOLDINGS LLC | Real Estate | $778M | 0.08% |
142REPX | RILEY EXPLORATION PERMIAN INC | Energy | $759M | 0.08% |
143CTO | CTO REALTY GROWTH INC | Real Estate | $751M | 0.07% |
144RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $750M | 0.07% |
145AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.07% |
146INN | SUMMIT HOTEL PROPERTIES INC | Real Estate | $722M | 0.07% |
147OMER | OMEROS CORP | Healthcare | $701M | 0.07% |
148MAMA | MAMA'S CREATIONS INC | Consumer Defensive | $700M | 0.07% |
149WASH | WASHINGTON TRUST BANCORP INC | Financial Services | $698M | 0.07% |
150SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.07% |
151DGICA | DONEGAL GROUP INC | Financial Services | $693M | 0.07% |
152TIPT | TIPTREE INC | Financial Services | $669M | 0.07% |
153CWH | CAMPING WORLD HOLDINGS INC | Consumer Cyclical | $637M | 0.06% |
154NFBK | NORTHFIELD BANCORP INC | Financial Services | $621M | 0.06% |
155FDMT | 4D MOLECULAR THERAPEUTICS INC | Healthcare | $575M | 0.06% |
156ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.05% |
157XMAX | XMAX INC | Consumer Cyclical | $541M | 0.05% |
158VSTM | VERASTEM INC | Healthcare | $530M | 0.05% |
159DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $517M | 0.05% |
160OIS | OIL STATES INTERNATIONAL INC | Energy | $507M | 0.05% |
161XOMA | XOMA ROYALTY CORP | Healthcare | $504M | 0.05% |
162OBT | ORANGE COUNTY BANCORP INC | Financial Services | $504M | 0.05% |
163CLMB | CLIMB GLOBAL SOLUTIONS INC | Technology | $482M | 0.05% |
164AMCX | AMC GLOBAL MEDIA INC | Communication Services | $461M | 0.05% |
165WTBA | WEST BANCORPORATION INC | Financial Services | $460M | 0.05% |
166PANL | PANGAEA LOGISTICS SOLUTIONS LTD | Industrials | $460M | 0.05% |
167PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.05% |
168TITN | TITAN MACHINERY INC | Industrials | $446M | 0.04% |
169SRTA | STRATA CRITICAL MEDICAL INC | Industrials | $446M | 0.04% |
170NEWT | NEWTEKONE INC | Financial Services | $439M | 0.04% |
171PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.04% |
172ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.04% |
173FPI | FARMLAND PARTNERS INC | Real Estate | $424M | 0.04% |
174CLFD | CLEARFIELD INC | Technology | $416M | 0.04% |
175SMC | SUMMIT MIDSTREAM CORP | Energy | $407M | 0.04% |
176ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.04% |
177TCI | TRANSCONTINENTAL REALTY INVESTORS INC | Real Estate | $394M | 0.04% |
178EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.04% |
179FLXS | FLEXSTEEL INDUSTRIES INC | Consumer Cyclical | $391M | 0.04% |
180STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.04% |
181VALU | VALUE LINE INC | Financial Services | $385M | 0.04% |
182LAND | GLADSTONE LAND CORP | Real Estate | $378M | 0.04% |
183CHMG | CHEMUNG FINANCIAL CORP | Financial Services | $366M | 0.04% |
184SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.03% |
185NODK | NI HOLDINGS INC | Financial Services | $326M | 0.03% |
186FVCB | FVCBANKCORP INC | Financial Services | $321M | 0.03% |
187JMSB | JOHN MARSHALL BANCORP INC | Financial Services | $313M | 0.03% |
188PAMT | PAMT CORP | Industrials | $311M | 0.03% |
189FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.03% |
190PNRG | PRIMEENERGY RESOURCES CORP | Energy | $302M | 0.03% |
191ASLE | AERSALE CORP | Industrials | $286M | 0.03% |
192FRAF | FRANKLIN FINANCIAL SERVICES CORP | Financial Services | $281M | 0.03% |
193LCNB | LCNB CORP | Financial Services | $273M | 0.03% |
194TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.03% |
195TBCH | TURTLE BEACH CORP | Technology | $258M | 0.03% |
196ARL | AMERICAN REALTY INVESTORS INC | Real Estate | $257M | 0.03% |
197RILY | BRC GROUP HOLDINGS INC | Financial Services | $254M | 0.03% |
198VABK | VIRGINIA NATIONAL BANKSHARES CORP | Financial Services | $250M | 0.02% |
199ASYS | AMTECH SYSTEMS INC | Technology | $242M | 0.02% |
200QUIK | QUICKLOGIC CORP | Technology | $237M | 0.02% |
201EFSI | EAGLE FINANCIAL SERVICES INC | Financial Services | $229M | 0.02% |
202ALOT | ASTRONOVA INC | Technology | $222M | 0.02% |
203FOA | FINANCE OF AMERICA COMPANIES INC | Financial Services | $216M | 0.02% |
204KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.02% |
205SENS | SENSEONICS HOLDINGS INC | Healthcare | $214M | 0.02% |
206GSIT | GSI TECHNOLOGY INC | Technology | $208M | 0.02% |
207IMUX | IMMUNIC INC | Healthcare | $207M | 0.02% |
208BDSX | BIODESIX INC | Healthcare | $204M | 0.02% |
209DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.02% |
210AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.02% |
211PAL | PROFICIENT AUTO LOGISTICS INC | Industrials | $197M | 0.02% |
212LARK | LANDMARK BANCORP INC | Financial Services | $190M | 0.02% |
213WHG | WESTWOOD HOLDINGS GROUP INC | Financial Services | $188M | 0.02% |
214BVFL | BV FINANCIAL INC | Financial Services | $186M | 0.02% |
215EBMT | EAGLE BANCORP MONTANA INC | Financial Services | $185M | 0.02% |
216CBFV | CB FINANCIAL SERVICES INC | Financial Services | $184M | 0.02% |
217PDEX | PRO DEX INC | Healthcare | $183M | 0.02% |
218OZ | BELPOINTE PREP LLC | Real Estate | $181M | 0.02% |
219INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $180M | 0.02% |
220HNVR | HANOVER BANCORP INC | Financial Services | $179M | 0.02% |
221KRRO | KORRO BIO INC | Healthcare | $177M | 0.02% |
222ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.02% |
223HQI | HIREQUEST INC | Industrials | $168M | 0.02% |
224EPSN | EPSILON ENERGY LTD | Energy | $167M | 0.02% |
225STRS | STRATUS PROPERTIES INC | Real Estate | $165M | 0.02% |
226FGBI | FIRST GUARANTY BANCSHARES INC | Financial Services | $164M | 0.02% |
227TRAK | REPOSITRAK INC | Technology | $160M | 0.02% |
228FNWD | FINWARD BANCORP | Financial Services | $157M | 0.02% |
229RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.02% |
230CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $146M | 0.01% |
231UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.01% |
232SIF | SIFCO INDUSTRIES INC | Industrials | $141M | 0.01% |
233OPRX | OPTIMIZERX CORP | Healthcare | $126M | 0.01% |
234GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | Financial Services | $123M | 0.01% |
235BOTJ | BANK OF THE JAMES FINANCIAL GROUP INC | Financial Services | $121M | 0.01% |
236SFBC | SOUND FINANCIAL BANCORP INC | Financial Services | $120M | 0.01% |
237BSBK | BOGOTA FINANCIAL CORP | Financial Services | $116M | 0.01% |
238FNWB | FIRST NORTHWEST BANCORP | Financial Services | $116M | 0.01% |
239TCX | TUCOWS INC | Technology | $114M | 0.01% |
240MGYR | MAGYAR BANCORP INC | Financial Services | $113M | 0.01% |
241TZOO | TRAVELZOO | Communication Services | $113M | 0.01% |
242RVSB | RIVERVIEW BANCORP INC | Financial Services | $107M | 0.01% |
243VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.01% |
244MHH | MASTECH DIGITAL INC | Industrials | $89M | 0.01% |
245RPT | RITHM PROPERTY TRUST INC | Real Estate | $85M | 0.01% |
246CPBI | CENTRAL PLAINS BANCSHARES INC | Industrials | $85M | 0.01% |
247INTG | INTERGROUP CORP | Consumer Cyclical | $84M | 0.01% |
248CPHC | CANTERBURY PARK HOLDING CORP | Consumer Cyclical | $82M | 0.01% |
249FSEA | FIRST SEACOAST BANCORP INC | Financial Services | $79M | 0.01% |
250ACET | ADICET BIO INC | Healthcare | $76M | 0.01% |
251BNAI | BRAND ENGAGEMENT NETWORK INC | Technology | $76M | 0.01% |
252AIRT | AIR T INC | Industrials | $73M | 0.01% |
253NSTS | NSTS BANCORP INC | Financial Services | $73M | 0.01% |
254HFBL | HOME FEDERAL BANCORP INC OF LOUISIANA | Financial Services | $70M | 0.01% |
255CLST | CATALYST BANCORP INC | Financial Services | $70M | 0.01% |
256LONA | LEONABIO INC | Healthcare | $68M | 0.01% |
257BGSF | BGSF INC | Industrials | $65M | 0.01% |
258IMA | IMAGENEBIO INC | Healthcare | $61M | 0.01% |
259LNZA | LANZATECH GLOBAL INC | Industrials | $56M | 0.01% |
260STEM | STEM INC | Technology | $56M | 0.01% |
261APT | ALPHA PRO TECH LTD | Basic Materials | $53M | 0.01% |
262MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.01% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.01T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 85% toward Large, 62% toward Growth. +3% unclassified (18 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 262 names now. The faded start covers early months with a much thinner universe. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual25.6%Margin-0.6%Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 262 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 16.0% | 15.6% |
| 3 yearsp.a. | 18.7% | -3.2% |
| 5 yearsp.a. | 10.2% | 1.2% |
| 10 yearsp.a. | 13.6% | 1.2% |
| Since inceptionp.a. | 10.5% | 6.7% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 10.5% | 15.2% |
| 2025 | 8.6% | -31.7% |
| 2024 | 29.4% | 11.3% |
| 2023 | 18.4% | 0.8% |
| 2022 | -11.2% | 15.9% |
| 2021 | 13.3% | 0.0% |
| 2020 | 36.0% | 9.7% |
| 2019 | 24.2% | -3.7% |
| 2018 | -7.5% | 8.7% |
| 2017 | 11.4% | -9.4% |
| 2016 | 21.6% | 10.7% |
| 2015 | -5.1% | 2.0% |
| 2014 | 9.7% | -0.3% |
| 2013 | 49.0% | 10.0% |
| 2012 | 24.3% | 17.5% |
| 2011 | -9.2% | -7.3% |
| 2010 | 10.6% | 0.1% |
| 2009 | 32.1% | 1.3% |
| 2008 | -39.6% | 30.8% |
| 2007 | -21.5% | -22.2% |
| 2006 | 28.1% | 11.7% |
| 2005 | 17.4% | 13.0% |
| 2004 | 10.8% | 0.3% |
| 2003 | 46.5% | 5.0% |
| 2002 | -23.3% | 10.1% |
| 2001 | 4.7% | 54.4% |
| 2000 | 31.3% | 102.0% |
| 1999 | 27.0% | -12.2% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Investment Discipline Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Investment Discipline signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.